Pfizer Inc Stock Price Patterns
| PFE Stock | USD 27.47 0.02 0.07% |
Momentum
Impartial
Oversold | Overbought |
Quarterly Earnings Growth -0.21 | EPS Estimate Next Quarter 0.7464 | EPS Estimate Current Year 2.9613 | EPS Estimate Next Year 2.8298 | Wall Street Target Price 28.4258 |
This view aligns Pfizer's headline activity with price response and peer context. Options positioning and short interest are used here to outline sentiment for Pfizer.
Short Interest for Pfizer
Short interest trends for Pfizer provide positioning context. This context is presented alongside price and volatility signals.
200 Day MA 25.204 | Short Percent 0.0251 | Short Ratio 2.95 | Shares Short Prior Month 143 M | 50 Day MA 26.4338 |
Pfizer Inc Hype-to-Price View
Attention trends around Pfizer are mapped to provide sentiment context. The view connects attention signals with observed price behavior.
The sentiment-to-price relationship for Pfizer is summarized for context. The context can be compared with fundamentals and volatility metrics.
Pfizer Implied Volatility | 0.39 |
Implied volatility for Pfizer provides a market-based measure of expected variability. The reading is provided as context for near-term price variability.
The attention view for Pfizer connects headline intensity with short-term volatility context.
Pfizer after-hype prediction price | $ 27.45 |
Sentiment indicators are one input among forecasting models, technical signals, analyst estimates, earnings data, and momentum measures.
Rule 16 Summary for current Pfizer contract
Using the Rule 16 heuristic, the current implied volatility suggests an average daily move of about 0.0244% for the 2026-06-18 options. At a recent price around $ 27.47, the implied daily move is approximately $ 0.01, which is informational only.
Pfizer Basic Forecasting Models can be used to cross-verify projections for Pfizer. This adds a model-based reference for the projection set.Mean reversion in Pfizer's price occurs when temporary dislocations - caused by sentiment extremes, news events, or liquidity shocks - correct back toward the stock's historical fair value.
After-Hype Price Density Analysis
Understanding Pfizer's probability distribution helps investors calibrate position size to their risk tolerance. The tails of the Pfizer distribution capture low-probability but high-impact outcomes that naive point estimates ignore.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
Using Pfizer's historical news impact data, we estimate the likely price corridor for the next trading session after a significant headline. Pfizer's after-hype downside and upside margins for the prediction period are 26.11 and 28.79, respectively. Note that past news reactions for Pfizer are not guaranteed to repeat, particularly in novel market environments.
Current Value
The after-hype framework applied to Pfizer Inc assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. The objective is to separate event-driven enthusiasm from a more stable price path once the market absorbs the catalyst.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Pfizer is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pfizer backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pfizer, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.19 | 1.36 | 0.10 | 0.17 | 11 Events | 7 Events | In 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
27.47 | 27.45 | 0.00 |
|
Hype Timeline
On the 18th of March 2026 Pfizer Inc is traded for 27.47. The company has historical hype elasticity of 0.1, and average elasticity to hype of competition of -0.17. Pfizer is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.19%. %. The volatility of related hype on Pfizer is about 149.61%, with the expected price after the next announcement by competition of 27.30. About 68.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.75. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pfizer Inc had its last dividend issued on the 23rd of January 2026. The company completed a 1054:1000 stock split on 17th of November 2020. Considering the 90-day investment horizon the next forecasted press release will be in 11 days. Pfizer Basic Forecasting Models can be used to cross-verify projections for Pfizer. This adds a model-based reference for the projection set.Related Hype Analysis
Understanding how Pfizer's direct competitors react to news events helps investors anticipate contagion effects and sector-wide sentiment shifts that may affect Pfizer's performance.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GILD | Gilead Sciences | -1.10 | 7 per month | 1.27 | 0.18 | 3.60 | -2.56 | 8.38 | |
| SNY | Sanofi ADR | -0.13 | 7 per month | 0.00 | -0.07 | 1.60 | -2.64 | 6.38 | |
| AMGN | Amgen Inc | 2.59 | 7 per month | 1.33 | 0.14 | 3.47 | -2.61 | 11.23 | |
| GSK | GlaxoSmithKline PLC ADR | -0.76 | 9 per month | 1.21 | 0.12 | 3.15 | -2.09 | 10.04 | |
| BMY | Bristol Myers Squibb | -0.02 | 6 per month | 0.90 | 0.21 | 3.30 | -1.88 | 6.78 | |
| SYK | Stryker | -5.96 | 8 per month | 0.00 | 0.02 | 2.20 | -1.99 | 8.63 | |
| MRK | Merck Company | -0.54 | 7 per month | 1.22 | 0.22 | 2.54 | -1.98 | 7.29 | |
| BSX | Boston Scientific Corp | -0.51 | 6 per month | 0.00 | -0.12 | 2.42 | -2.82 | 21.15 | |
| NVO | Novo Nordisk AS | -0.66 | 5 per month | 0.00 | -0.06 | 5.19 | -6.18 | 26.35 | |
| DHR | Danaher | -2.00 | 12 per month | 0.00 | -0.13 | 2.07 | -3.05 | 8.05 |
Pfizer Additional Predictive Modules
Forecasting Pfizer's price movement relies on structured analysis of indicator behavior, momentum signatures, and historical volatility patterns. Ensemble techniques that blend multiple model outputs often produce more stable predictions than any single model.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sentiment Indicators & Methodology
Sentiment analysis for Pfizer evaluates news tone, positioning, and narrative momentum. Positioning shifts can amplify volatility changes during regime transitions. Pfizer has a market cap of 151.31 B, P/E of 9.48, ROE of 8.89%.
This section for Pfizer Inc is built from periodic company reporting and market reference feeds, with harmonization applied to align reporting definitions. Professional analyst research is incorporated when coverage is available. Values may update on different source schedules.
This content is curated and reviewed by:
Ellen Johnson - Member of Macroaxis Editorial BoardAlso Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Popular Tools for Pfizer Stock analysis
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |